Turtle Creek Wealth Advisors LLC Purchases 1,807 Shares of UnitedHealth Group Incorporated $UNH

Turtle Creek Wealth Advisors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 18,808 shares of the healthcare conglomerate’s stock after acquiring an additional 1,807 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $5,089,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. DB Fitzpatrick & Co Inc boosted its holdings in UnitedHealth Group by 11.8% in the first quarter. DB Fitzpatrick & Co Inc now owns 5,268 shares of the healthcare conglomerate’s stock worth $1,425,000 after acquiring an additional 556 shares in the last quarter. Sierra Summit Advisors LLC raised its position in shares of UnitedHealth Group by 3.2% in the 1st quarter. Sierra Summit Advisors LLC now owns 6,912 shares of the healthcare conglomerate’s stock valued at $1,870,000 after purchasing an additional 217 shares during the last quarter. Leonteq Securities AG boosted its stake in UnitedHealth Group by 4.5% in the 1st quarter. Leonteq Securities AG now owns 71,025 shares of the healthcare conglomerate’s stock worth $19,219,000 after purchasing an additional 3,081 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in UnitedHealth Group by 55.0% during the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 374,508 shares of the healthcare conglomerate’s stock valued at $101,338,000 after purchasing an additional 132,930 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 65.5% during the first quarter. Elevation Point Wealth Partners LLC now owns 16,731 shares of the healthcare conglomerate’s stock worth $4,527,000 after buying an additional 6,621 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Leerink Partners upped their target price on UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a research report on Wednesday, June 17th. Robert W. Baird boosted their price target on UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a research note on Wednesday, April 22nd. Barclays lifted their target price on UnitedHealth Group from $373.00 to $429.00 and gave the stock an “overweight” rating in a report on Tuesday, May 26th. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, June 23rd. Finally, Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective for the company in a research note on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $411.42.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by insiders.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth was highlighted in an article arguing that its turnaround is continuing into the upcoming Q2 report, which suggests investors are looking for improving fundamentals and potential upside if execution stays on track. UnitedHealth Group: The Turnaround Continues Into The Q2 Report
• Positive Sentiment: Guardant Health said UnitedHealth will begin covering its Shield blood test for colorectal cancer screening on August 1, a move that may reinforce UNH’s reputation for supporting preventive care and could be viewed favorably by investors. UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
• Neutral Sentiment: Several articles focused on UNH being “attracting investor attention” and on its Q1 earnings relative to peers, but these pieces were mostly informational rather than new catalysts, so they likely contributed to trading interest more than a decisive price move. UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
• Negative Sentiment: One piece warned that UnitedHealth faces a “Medicare reset,” which points to potential pressure on the company’s Medicare Advantage economics and could weigh on sentiment if reimbursement or margin assumptions soften. UnitedHealth Group (NYSE:UNH) Faces Medicare Reset

UnitedHealth Group Stock Down 0.4%

Shares of UNH opened at $424.64 on Friday. The stock’s 50-day moving average price is $391.45 and its 200-day moving average price is $335.01. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $385.63 billion, a price-to-earnings ratio of 32.07, a PEG ratio of 1.71 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $430.20.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the previous year, the company posted $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a $2.32 dividend. The ex-dividend date of this dividend was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. UnitedHealth Group’s dividend payout ratio is presently 70.09%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.